CHEK2 and breast carcinoma: Regarding breast cancer, in addition to the known high-penetrance pathogenic variants of BRCA1/2, mutations in other high- or intermediate-penetrance genes can increase the risk of cancer [21] and the most common non-BRCA pathogenic or likely pathogenic variants affect PALB2, ATM, and CHEK2 genes [22].